140 related articles for article (PubMed ID: 36877873)
1. Skin of Color Representation in Clinical Trials: An Analysis of Clinicaltrials.gov From 2008-2022.
Jacobs J; Lebhar J; Diamond C; Rundle C; Stamey C
J Drugs Dermatol; 2023 Mar; 22(3):310-311. PubMed ID: 36877873
[TBL] [Abstract][Full Text] [Related]
2. Racial and ethnic underrepresentation in dermatology clinical trials.
Mineroff J; Nguyen JK; Jagdeo J
J Am Acad Dermatol; 2023 Aug; 89(2):293-300. PubMed ID: 37062462
[TBL] [Abstract][Full Text] [Related]
3. Gender, racial, ethnic, and Fitzpatrick skin type representation in Acanthosis nigricans clinical trials.
Wang JY; Bitterman D; Patel P; Kabakova M; Zafar K; Cohen M; Jagdeo J
Arch Dermatol Res; 2024 Jun; 316(6):332. PubMed ID: 38842735
[TBL] [Abstract][Full Text] [Related]
4. Insights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes.
Alexis A; Woolery-Lloyd H; Andriessen A; Callender V; Gonzalez M; Heath C; Han G
J Drugs Dermatol; 2022 May; 21(5):462-470. PubMed ID: 35533036
[TBL] [Abstract][Full Text] [Related]
5. Minimizing Bias in Alopecia Diagnosis in Skin of Color Patients.
Balazic E; Axler E; Nwankwo C; Kim R; Lo Sicco K; Kobets K; Adotama P
J Drugs Dermatol; 2023 Jul; 22(7):703-705. PubMed ID: 37410034
[TBL] [Abstract][Full Text] [Related]
6. Racial/Ethnic Variations in Acne: Implications for Treatment and Skin Care Recommendations for Acne Patients With Skin of Color.
Alexis AF; Woolery-Lloyd H; Williams K; Andriessen A; Callender VD; Kang S; Rodriquez D; Tan J
J Drugs Dermatol; 2021 Jul; 20(7):716-725. PubMed ID: 34232006
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of Chronic Dermatologic Conditions in Skin of Color.
Bourgeois JC; Beer J; Choi SH; Bitar C
J Drugs Dermatol; 2023 Nov; 22(11):e21-e23. PubMed ID: 37943262
[TBL] [Abstract][Full Text] [Related]
8. Disparities in Race and Ethnicity Reporting and Representation for Clinical Trials in Stroke: 2010 to 2020.
Nanavati HD; Andrabi M; Arevalo YA; Liu E; Shen J; Lin C
J Am Heart Assoc; 2024 Mar; 13(6):e033467. PubMed ID: 38456461
[TBL] [Abstract][Full Text] [Related]
9. Top dermatologic conditions in patients of color: an analysis of nationally representative data.
Davis SA; Narahari S; Feldman SR; Huang W; Pichardo-Geisinger RO; McMichael AJ
J Drugs Dermatol; 2012 Apr; 11(4):466-73. PubMed ID: 22453583
[TBL] [Abstract][Full Text] [Related]
10. The Psychosocial Burden of Skin Disease and Dermatology Care Insights Among Skin of Color Consumers.
Cartwright MM; Kamen T; Desai SR
J Drugs Dermatol; 2023 Oct; 22(10):1027-1033. PubMed ID: 37801524
[TBL] [Abstract][Full Text] [Related]
11. Racial and Ethnic Disparities in Primary Open-Angle Glaucoma Clinical Trials: A Systematic Review and Meta-analysis.
Allison K; Patel DG; Greene L
JAMA Netw Open; 2021 May; 4(5):e218348. PubMed ID: 34003274
[TBL] [Abstract][Full Text] [Related]
12. Scarring and Dyschromias in Fitzpatrick Skin Type IV-VI: A Review of Dermatologic Treatment Protocols.
Bourgeois J; Beer J; Jacob L; Henry M
J Drugs Dermatol; 2023 Jul; 22(7):7253. PubMed ID: 37410031
[TBL] [Abstract][Full Text] [Related]
13. Ethnoracial representation in hidradenitis suppurativa clinical trials.
Elhage KG; Davis MS; Hakimi M; Spencer RK; Jin JQ; Yeroushalmi S; Chung M; Bartholomew E; Bhutani T; Liao W
Arch Dermatol Res; 2023 Aug; 315(6):1793-1796. PubMed ID: 36509944
[TBL] [Abstract][Full Text] [Related]
14. Assessment of skin of color and diversity and inclusion content of dermatologic published literature: An analysis and call to action.
Wilson BN; Sun M; Ashbaugh AG; Ohri S; Yeh C; Murrell DF; Murase JE
Int J Womens Dermatol; 2021 Sep; 7(4):391-397. PubMed ID: 34621950
[TBL] [Abstract][Full Text] [Related]
15. Special Considerations of Atopic Dermatitis in Skin of Color.
Marcelletti A; Shan DM; Abdi W; Lovell K; Obeime I; McMichael A
Adv Exp Med Biol; 2024; 1447():45-57. PubMed ID: 38724783
[TBL] [Abstract][Full Text] [Related]
16. Race and Ethnicity Representation in Phase 2/3 Oncology Clinical Trial Publications: A Systematic Review.
Taparra K; Benavente R; Shih JJ; Gimmen MY; Tominez P; Kekumano KE; Pineda E; Halualani G; Cakobau H; Ludmir EB; Deville C; Peppercorn J; Gomez SL; Bosserman L; Chino F; Patel MI; Shah C
JAMA Health Forum; 2024 Jun; 5(6):e241388. PubMed ID: 38848090
[TBL] [Abstract][Full Text] [Related]
17. Toward representative genomic research: the children's rare disease cohorts experience.
Frazier ZJ; Brown E; Rockowitz S; Lee T; Zhang B; Sveden A; Chamberlin NL; Dies KA; Poduri A; Sliz P; Chopra M
Ther Adv Rare Dis; 2023; 4():26330040231181406. PubMed ID: 37621556
[TBL] [Abstract][Full Text] [Related]
18. Patient-Reported Outcomes in Acne Patients With Skin of Color Using Adapalene 0.3%-Benzoyl Peroxide 2.5%: A Prospective Real-World Study.
DuBois J; Ong GCW; Petkar G; Almeida LMC; Chavda R; Kerrouche N; Alexis AF
J Drugs Dermatol; 2019 Jun; 18(5):514. PubMed ID: 31251543
[TBL] [Abstract][Full Text] [Related]
19. U.S. racial and ethnic participation in global clinical trials by therapeutic areas.
Lolic M; Araojo R; Okeke M; Temple R
J Clin Pharm Ther; 2021 Dec; 46(6):1576-1581. PubMed ID: 34544200
[TBL] [Abstract][Full Text] [Related]
20. Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis.
Kontzias CL; Curcio A; Gorodokin B; Tissera KA; Feldman SR; Bhatia N; Callender VD; Kircik L
J Drugs Dermatol; 2023 Jul; 22(7):668-672. PubMed ID: 37410050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
